Piperidinylaminomethyl Trifluoromethyl Cyclic Ether Compound 1

Piperidinylaminomethyl Trifluoromethyl Cyclic Ether Compound 1 has the potential function in central nervous system disorders, respiratory, inflammatory diseases and gastrointestinal disorders.

Signaling Pathways >> Others >> Others

Research Areas >> Neurological Disease

Research Areas >> Inflammation/Immunology

Piperidinylaminomethyl Trifluoromethyl Cyclic Ether Compound 1 has the potential function in numerous diseases, including central nervous system disorders such as depression, anxiety and schizophrenia, in respiratory and inflammatory diseases such as asthma and rheumatoid arthritis, in gastrointestinal disorders and diseases of the GI tract such as ulcerative colitis and Crohn's disease, and in the transmission of pain, including migraine[1].

[1]. Caron, Stephane, et al. Process for the preparation of piperidinylaminomethyl trifluoromethyl cyclic ether compounds. EP1095939 A2.

Captisol | Cyclosporin A | H2DCFDA | 0MPTP hydrochloride | GW4869 | Etomoxir | TD139 | Mitoquinone mesylate | GSK2795039 | JC-1 | BAPTA-AM | AP 20187 | Setanaxib (GKT137831) | D-Luciferin | Crotaline